Tuesday, April 25, 2017
Heron Therapeutics Names CFO
San Diego-based Heron Therpaeutics, a biotechnology firm developing treatments for pain, has named Robert E. Hoffman as its Chief Financial Officer and Senior, Vice President, Finance. Hoffman was recently serving as EVP and CFO of Innovus Pharmaceuticals for the last eight months, and also was recently CFO of AnaptysBio. Hoffman also has been at Arena Pharmaceuticals and Polaris Group, and is on the board of CombiMatrix, Kura Oncology, and MabVax Therapeutic Holdings.